{"disease":{"id":"cerebral-adrenoleukodystrophy-cald","name":"cerebral adrenoleukodystrophy cald"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06224413","title":"A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":false},{"nct_id":"NCT03852498","title":"A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":true},{"nct_id":"NCT01896102","title":"A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Genetix Biotherapeutics Inc.","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}